Licensure of a meningococcal conjugate vaccine (Menveo) and guidance for use - Advisory Committee on Immunization Practices (ACIP), 2010.
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

superseded


Prevention and control of meningococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP)
Licensure of a meningococcal conjugate vaccine (Menveo) and guidance for use - Advisory Committee on Immunization Practices (ACIP), 2010.
  • Published Date:

    March 12, 2010

  • Source:
    MMWR. Morbidity and mortality weekly report. 2010; 59(9):273.
  • Language:
    English
Filetype[PDF-1.59 MB]


Details:
  • Supporting Files:
    No Additional Files
No Related Documents.

You May Also Like:

  1. Corporate Authors:
    United States. Advisory Committee on Immunization Practices.
    Published Date:
    January 28, 2011
    Source:
    MMWR. Morbidity and mortality weekly report. 2011; 60(3):72-6.
    Description:
    On October 27, 2010, the Advisory Committee on Immunization Practices (ACIP) approved updated recommendations for the use of quadrivalent (serogroups ...
    Status:
    superseded
    File Type:
    Filetype[HTM]
    File Type:
    Filetype[HTM]
  2. Corporate Authors:
    United States. Advisory Committee on Immunization Practices.
    Published Date:
    August 10, 2007
    Source:
    MMWR. Morbidity and mortality weekly report. 2007; 56(31):794-5.
    Description:
    In January 2005, a quadrivalent meningococcal polysaccharide- protein conjugate vaccine (MCV4) (Menactra™, Sanofi Pasteur, Inc., Swiftwater, Pennsyl...
    Status:
    superseded
    File Type:
    Filetype[PDF - 515.21 KB]
    File Type:
    Filetype[PDF - 515.21 KB]
  3. Corporate Authors:
    United States. Advisory Committee on Immunization Practices.
    Published Date:
    August 11, 2011
    Source:
    MMWR. Morbidity and mortality weekly report. 2011; 60(30):1018-9.
    Description:
    In January 2011, the Food and Drug Administration lowered the approval age range for use of MenACWY-CRM (Menveo, Novartis Vaccines and Diagnostics), a...
    Status:
    superseded
    File Type:
    Filetype[PDF - 72.15 KB]
    File Type:
    Filetype[PDF - 72.15 KB]
  4. Personal Author:
    Patton, Monica E. ; Stephens, David ; ...
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.
    Published Date:
    May 19 2017
    Source:
    MMWR Morb Mortal Wkly Rep. 66(19):509-513.
    Description:
    Two serogroup B meningococcal (MenB) vaccines are currently licensed for use in persons aged 10-25 years in the United States. The two vaccines are Me...
    File Type:
    Filetype[PDF - 142.10 KB]
    File Type:
    Filetype[PDF - 142.10 KB]
  5. Personal Author:
    Perkins, Bradley A. ; Rosenstein, Nancy E. ;
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices. ; Centers for Disease Control and Prevention (U.S.) ; ...
    Published Date:
    June 30, 2000
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 49, no. RR-7
    Description:
    Prevention and control of meningococcal disease: This report summarizes and updates an earlier published statement issued by the Advisory Committee on...
    File Type:
    Filetype[PDF - 179.37 KB]
    File Type:
    Filetype[PDF - 179.37 KB]